Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Kolltan Pharmaceuticals
A company developing monoclonal antibody therapeutics for the treatment of cancer
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
Acquirer
Celldex Therapeutics
0
AngelList URL
angel.co/kolltan-ph...maceuticals
B2X
B2B
0
CAGE Code
5DTJ3
0
CIK Number
1,442,835
0
Crunchbase URL
crunchbase.com/organiz...euticals
DUNS Number
015853037
0
Facebook URL
@pages/Kolltan-Pharmaceuticals-Inc/193169757364347
Founded Date
2014
0
Full Address
300 George Street, Suite 530, New Haven, CT 06511, US
Industry
Technology
Biology
Biotechnology
Investors
Fidelity Investments
HBM BioVentures
Elm Street Ventures
Auven Therapeutics
Purdue Pharma
Latest Funding Round Date
March 8, 2012
Latest Funding Type
Series C
LinkedIn URL
@company/kolltan-pharmaceuticals-inc.
Location
New Haven, Connecticut
Number of Employees (Ranges)
11 – 50
Pitchbook URL
pitchbook.com/profiles.../53576-02
Place of Incorporation
Delaware
0
Public/Private
Private
SIC Code
2,834
0
Total Funding Amount (USD)
40,000,000
Official Website
kolltan.com
Wellfound ID
kolltan-pharmaceuticals
Find more companies like Kolltan Pharmaceuticals
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE